Search results
Moderna Stock Seesaws After The FDA Throws It A Curveball
Investor's Business Daily· 6 days agoThe FDA was due to make a decision by May 12. Moderna emphasized the FDA has not said it found any...
Moderna says FDA delayed RSV vaccine approval to end of May
CNBC· 7 days agoModerna on Friday said the Food and Drug Administration has delayed the approval of its vaccine for...
Investors Heavily Search Moderna, Inc. (MRNA): Here is What You Need to Know
Zacks· 4 days agoFree Report) is one of the stocks most watched by Zacks.com visitors lately. Over the past month, shares of this biotechnology company have returned +11.6%, compared to the Zacks S&P 500 composite's ...
Moderna says FDA will not complete review of RSV vaccine by May 12 deadline
Market Watch· 7 days agoModerna Inc.’s stock fell 2.6% Friday, after the company said the Food and Drug Administration will...
Moderna's RSV Vaccine Approval Faces Setback as FDA Delays Decision
Homenewshere.com· 6 days agoModerna announced that the FDA had delayed approval of its RSV vaccine to the end of May due to...
Moderna to Present at Upcoming Conferences in May/June 2024
The Sacramento Bee· 4 days agoModerna, Inc. (Nasdaq:MRNA), today announced its participation in the following upcoming investor conferences:
FDA delays decision date for Moderna's RSV vaccine - Boston Business Journal
The Business Journals· 6 days agoJust days before its deadline, the U.S. Food and Drug Administration says it's giving itself more...
Unveiling Moderna (MRNA)'s Value: Is It Really Priced Right? A C
Guru Focus· 3 days agoModerna Inc (MRNA, Financial) has recently shown a notable daily gain of 5.55%, with a three-month gain of 34.21%. Despite these impressive numbers, a deeper look into the ...
Wealthspire Advisors LLC Has $301,000 Stock Position in Moderna, Inc. (NASDAQ:MRNA)
ETF DAILY NEWS· 5 days agoWealthspire Advisors LLC trimmed its stake in Moderna, Inc. (NASDAQ:MRNA – Free Report) by 7.9% in the fourth quarter, according to its most recent disclosure with the Securities ...
Moderna Tumbles After The FDA Throws A Curveball On Its Second Product
Investor's Business Daily· 6 days agoModerna stock toppled Friday after the Food and Drug Administration delayed an approval decision on...